Clinical Trial Update: A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant [Phase 2]

View source ↗

Summary

The update describes a Phase 2 study of a modified dose of rabbit anti-thymocyte globulin (rATG) used to condition patients (children and adults) before bone ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL) | Phase 2 | Status: ACTIVE_NOT_RECRUITING